scholarly article | Q13442814 |
P2093 | author name string | Rong Zhang | |
Jian Q Feng | |||
Ling Ye | |||
Lynda F Bonewald | |||
Tian Gao | |||
Chunlin Qin | |||
Yongbo Lu | |||
Baozhi Yuan | |||
Marc K Drezner | |||
Shibin Yu | |||
Yixia Xie | |||
P2860 | cites work | DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. | Q54943458 |
Osteomalacia in hyp mice is associated with abnormal phex expression and with altered bone matrix protein expression and deposition | Q73400284 | ||
DMP1 depletion decreases bone mineralization in vivo: an FTIR imaging analysis | Q24545780 | ||
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia | Q24623628 | ||
Genetic evidence of serum phosphate-independent functions of FGF-23 on bone | Q28473286 | ||
Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice | Q28507303 | ||
The parathyroid is a target organ for FGF23 in rats | Q28572613 | ||
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism | Q29620323 | ||
Dmp1-deficient mice display severe defects in cartilage formation responsible for a chondrodysplasia-like phenotype | Q33209762 | ||
Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization | Q34035649 | ||
Buried alive: how osteoblasts become osteocytes | Q34463986 | ||
E11/gp38 selective expression in osteocytes: regulation by mechanical strain and role in dendrite elongation | Q34718158 | ||
Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice. | Q35083898 | ||
Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice | Q35094674 | ||
The phosphatonin pathway: new insights in phosphate homeostasis | Q35607596 | ||
Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. | Q35728669 | ||
Rescue of odontogenesis in Dmp1-deficient mice by targeted re-expression of DMP1 reveals roles for DMP1 in early odontogenesis and dentin apposition in vivo | Q36111621 | ||
Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. | Q36649088 | ||
Pathogenic role of Fgf23 in Dmp1-null mice. | Q36846110 | ||
Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization | Q36848109 | ||
Dentin matrix protein 1 (DMP1): new and important roles for biomineralization and phosphate homeostasis | Q37014020 | ||
The osteocyte lineage | Q37142831 | ||
Molecular analysis of DMP1 mutants causing autosomal recessive hypophosphatemic rickets | Q37160599 | ||
FGF23-parathyroid interaction: implications in chronic kidney disease | Q37654689 | ||
The biological function of DMP-1 in osteocyte maturation is mediated by its 57-kDa C-terminal fragment | Q38553300 | ||
MLO-Y4 osteocyte-like cells support osteoclast formation and activation | Q40692837 | ||
Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers. | Q40862972 | ||
Osteoclast differentiation requires ascorbic acid | Q42456639 | ||
Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia | Q44203982 | ||
Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23. | Q44465622 | ||
Evidence for the proteolytic processing of dentin matrix protein 1. Identification and characterization of processed fragments and cleavage sites | Q44482171 | ||
Deletion of dentin matrix protein-1 leads to a partial failure of maturation of predentin into dentin, hypomineralization, and expanded cavities of pulp and root canal during postnatal tooth development | Q46285814 | ||
The Dentin Matrix Protein 1 (Dmp1) is Specifically Expressed in Mineralized, but not Soft, Tissues during Development | Q46286402 | ||
Pathogenic role of Fgf23 in Hyp mice. | Q46921328 | ||
Dentin matrix protein 1, a target molecule for Cbfa1 in bone, is a unique bone marker gene. | Q52114022 | ||
Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. | Q54454988 | ||
P433 | issue | 5 | |
P304 | page(s) | 1047-1056 | |
P577 | publication date | 2011-05-01 | |
P1433 | published in | Journal of Bone and Mineral Research | Q15750941 |
P1476 | title | Unique roles of phosphorus in endochondral bone formation and osteocyte maturation | |
P478 | volume | 26 |
Q50170613 | A novel auditory ossicles membrane and the development of conductive hearing loss in Dmp1-null mice |
Q52718216 | Abnormally High and Heterogeneous Bone Matrix Mineralization After Childhood Solid Organ Transplantation: A Complex Pathology of Low Bone Turnover and Local Defects in Mineralization. |
Q47707463 | Activating the unfolded protein response in osteocytes causes hyperostosis consistent with craniodiaphyseal dysplasia. |
Q61448591 | Bioactive calcium phosphate materials and applications in bone regeneration |
Q38257346 | Bone development and mineral homeostasis in the fetus and neonate: roles of the calciotropic and phosphotropic hormones |
Q36377662 | Chondrocytes Directly Transform into Bone Cells in Mandibular Condyle Growth |
Q38601521 | Chondrogenesis and osteogenesis are one continuous developmental and lineage defined biological process |
Q51701907 | Comparing the expression patterns of placental magnesium/phosphorus-transporting channels between healthy and preeclamptic pregnancies. |
Q33985338 | Constitutive nuclear expression of dentin matrix protein 1 fails to rescue the Dmp1-null phenotype |
Q37331955 | Dairy in adulthood: from foods to nutrient interactions on bone and skeletal muscle health |
Q39330227 | Deconvoluting the Bioactivity of Calcium Phosphate-Based Bone Graft Substitutes: Strategies to Understand the Role of Individual Material Properties |
Q37367279 | Dietary phosphate supplement does not rescue skeletal phenotype in a mouse model for craniometaphyseal dysplasia |
Q37348702 | Dmp1 Null Mice Develop a Unique Osteoarthritis-like Phenotype |
Q34269222 | Extracellular matrix mineralization promotes E11/gp38 glycoprotein expression and drives osteocytic differentiation |
Q38890172 | FGF23 Is Not Associated With Age-Related Changes in Phosphate, but Enhances Renal Calcium Reabsorption in Girls. |
Q49873034 | FGF23 Is Not Required to Regulate Fetal Phosphorus Metabolism but Exerts Effects Within 12 Hours After Birth |
Q51701483 | FGF23 Neutralizing Antibody Ameliorates Hypophosphatemia and Impaired FGF Receptor Signaling in Kidneys of HMWFGF2 Transgenic Mice. |
Q38087548 | FGF23 associated bone diseases |
Q35707031 | FGF23 in skeletal modeling and remodeling |
Q36639867 | FGF23 production by osteocytes |
Q26866263 | Fibroblast Growth Factor 23: A New Dimension to Diseases of Calcium-Phosphorus Metabolism |
Q89893867 | High-Phosphate Diet Improved the Skeletal Development of Fam20c-Deficient Mice |
Q38045788 | Hypophosphatemic rickets: unraveling the role of FGF23. |
Q35710380 | Identification of a Mutation in FGF23 Involved in Mandibular Prognathism |
Q57788172 | Impaired osteocyte maturation in the pathogenesis of renal osteodystrophy |
Q38379782 | In vitro and in vivo bioactivity assessment of a polylactic acid/hydroxyapatite composite for bone regeneration |
Q33649249 | Induced ablation of Bmp1 and Tll1 produces osteogenesis imperfecta in mice |
Q34075193 | Integrin-mediated signaling contributes to gadolinium-containing-particle-promoted cell survival and G₁ to S phase cell cycle transition by enhancing focal adhesion formation |
Q36592828 | Interactions between calcium and phosphorus in the regulation of the production of fibroblast growth factor 23 in vivo |
Q99238029 | Linear and Non-linear Correlations Between Serum Phosphate Level and Bone Mineral Density in Type 2 Diabetes |
Q37709199 | Neither absence nor excess of FGF23 disturbs murine fetal-placental phosphorus homeostasis or prenatal skeletal development and mineralization. |
Q36280326 | Npt2b deletion attenuates hyperphosphatemia associated with CKD. |
Q42107342 | Nuclear localization of DMP1 proteins suggests a role in intracellular signaling |
Q35046820 | Osteoblast-osteocyte transformation. A SEM densitometric analysis of endosteal apposition in rabbit femur |
Q38081019 | Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia |
Q38845640 | Osteocytic signalling pathways as therapeutic targets for bone fragility |
Q36367168 | Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice. |
Q36081136 | PTH and Vitamin D Repress DMP1 in Cementoblasts. |
Q64077732 | PTH decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation |
Q37492019 | Phosphate: an old bone molecule but new cardiovascular risk factor |
Q38121133 | Potential health concerns of dietary phosphorus: cancer, obesity, and hypertension |
Q27325653 | Protective roles of DMP1 in high phosphate homeostasis |
Q91458078 | Role of phosphate sensing in bone and mineral metabolism |
Q36923887 | Sclerostin antibody (Scl-Ab) improves osteomalacia phenotype in dentin matrix protein 1(Dmp1) knockout mice with little impact on serum levels of phosphorus and FGF23. |
Q40344912 | Serum Phosphate Is Associated With Fracture Risk: The Rotterdam Study and MrOS. |
Q33804104 | Specific ablation of mouse Fam20C in cells expressing type I collagen leads to skeletal defects and hypophosphatemia |
Q34139850 | The calcium-sensing receptor complements parathyroid hormone-induced bone turnover in discrete skeletal compartments in mice |
Q36482983 | The effects of maternal iron deficiency on infant fibroblast growth factor-23 and mineral metabolism. |
Q37203605 | The osteocyte: an endocrine cell ... and more |
Q36666239 | The rescue of dentin matrix protein 1 (DMP1)-deficient tooth defects by the transgenic expression of dentin sialophosphoprotein (DSPP) indicates that DSPP is a downstream effector molecule of DMP1 in dentinogenesis |
Q38050402 | The skeleton as an endocrine organ |
Q33707936 | Transglutaminase regulation of cell function. |
Q33817077 | Twist1- and Twist2-haploinsufficiency results in reduced bone formation |
Q50307311 | Vital Roles of β-catenin in Trans-differentiation of Chondrocytes to Bone Cells. |
Search more.